Status:
UNKNOWN
Analysis of miRNA Expression in Endometrial Cancer
Lead Sponsor:
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Conditions:
Endometrial Cancer
Eligibility:
FEMALE
18+ years
Brief Summary
The TCGA project identified four distinct prognostic groups of endometrial carcinoma (EC) based on molecular alterations: (i) the ultramutated subtype that encompasses POLE mutated (POLE) cases; (ii) ...
Eligibility Criteria
Inclusion
- age\>18yo
- histological diagnosis of endometrial cancer
- tumor resection
- patient's informed consent
Exclusion
- patients with other neoplasia within the last 5 years
Key Trial Info
Start Date :
April 1 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2022
Estimated Enrollment :
150 Patients enrolled
Trial Details
Trial ID
NCT04845425
Start Date
April 1 2021
End Date
December 1 2022
Last Update
July 21 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
IRCCS- Azienda Ospedaliera-Universitaria di Bologna
Bologna, Bo, Italy, 40138